1. Home
  2. DKL vs RXRX Comparison

DKL vs RXRX Comparison

Compare DKL & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DKL

Delek Logistics Partners

HOLD

Current Price

$48.88

Market Cap

2.4B

Sector

Energy

ML Signal

HOLD

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$4.60

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DKL
RXRX
Founded
2012
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DKL
RXRX
Price
$48.88
$4.60
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$45.50
$7.50
AVG Volume (30 Days)
61.5K
20.8M
Earning Date
02-24-2026
02-27-2026
Dividend Yield
9.16%
N/A
EPS Growth
9.17
N/A
EPS
3.09
N/A
Revenue
$967,420,000.00
$43,689,000.00
Revenue This Year
$11.84
$6.74
Revenue Next Year
$10.55
$34.31
P/E Ratio
$15.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.59
$3.79
52 Week High
$49.23
$12.36

Technical Indicators

Market Signals
Indicator
DKL
RXRX
Relative Strength Index (RSI) 67.01 49.63
Support Level $48.01 $4.55
Resistance Level $49.02 $5.24
Average True Range (ATR) 1.22 0.28
MACD 0.18 0.00
Stochastic Oscillator 100.00 25.84

Price Performance

Historical Comparison
DKL
RXRX

About DKL Delek Logistics Partners

Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: